Hyperthermia after the use of sublingual misoprostol in the management of uterine atony

Authors

DOI:

https://doi.org/10.5377/alerta.v3i1.8959

Keywords:

Misoprostol, hyperthermia, postpartum hemorrhage.

Abstract

Abstract

Hyperthermia secondary to the use of sublingual misoprostol is reported in the literature; in some cases, it requires management in intensive care units. We present the case of a patient with postpartum hemorrhage due to uterine atony, who receives an 800 micrograms dose of sublingual misoprostol, subsequently presenting hyperpyrexia, as part of her clinical evolution and management. Currently, the International Federation of Gynecology and Obstetrics recommends an 800 micrograms sublingual dose schedule. A patient with hyperthermia associated with the use of sublingual misoprostol is presented, with good clinical evolution.

Downloads

Download data is not yet available.
Abstract
2654
PDF (Español (España)) 2007

Downloads

Published

2020-01-27

How to Cite

López Guevara, R. E. (2020). Hyperthermia after the use of sublingual misoprostol in the management of uterine atony. Alerta, Revista científica Del Instituto Nacional De Salud, 3(1), 9–12. https://doi.org/10.5377/alerta.v3i1.8959

Issue

Vol. 3 No. 1 (2020)

Section

Case Report

License

Privacy statement:

Alerta articles are published under license Creative Commons 4.0 CC BY: https://creativecommons.org/licenses/by/4.0/

Authorship rights

Revista Alerta gives the authors exclusive control of their work and the right to be acknowledged and cited.